Global Influenza Diagnostics Market Insights, Forecast to 2029

Publisher Name :
Date: 21-Sep-2023
No. of pages: 105
Inquire Before Buying

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Market Analysis and Insights: Global Influenza Diagnostics Market

The global Influenza Diagnostics market is projected to grow from US$ 2495.1 million in 2023 to US$ 3599.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

Report Includes

This report presents an overview of global market for Influenza Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Influenza Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Influenza Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Influenza Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Influenza Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc.

By Company

- BD

- Abbott (Include Alere)

- Roche

- SIEMENS

- Analytik Jena

- Quidel

- Thermo Fisher

- Meridian Bioscience

- BioMerieux

- Sekisui Diagnostics

- Response Biomedical

- SA Scientific

Segment by Type

- RIDT

- RT-PCR

- Cell Culture

- Others

Segment by Application

- Hospitals

- POCT

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Influenza Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Diagnostics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Influenza Diagnostics Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2018-2029)
2.2 Global Influenza Diagnostics Growth Trends by Region
2.2.1 Influenza Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Influenza Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Influenza Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Influenza Diagnostics Market Dynamics
2.3.1 Influenza Diagnostics Industry Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Influenza Diagnostics by Players
3.1.1 Global Influenza Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Influenza Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2022
3.5 Global Key Players of Influenza Diagnostics Head office and Area Served
3.6 Global Key Players of Influenza Diagnostics, Product and Application
3.7 Global Key Players of Influenza Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2024-2029)
5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Influenza Diagnostics Market Size (2018-2029)
6.2 North America Influenza Diagnostics Market Size by Type
6.2.1 North America Influenza Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Influenza Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Influenza Diagnostics Market Share by Type (2018-2029)
6.3 North America Influenza Diagnostics Market Size by Application
6.3.1 North America Influenza Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Influenza Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Influenza Diagnostics Market Share by Application (2018-2029)
6.4 North America Influenza Diagnostics Market Size by Country
6.4.1 North America Influenza Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Influenza Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Influenza Diagnostics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size (2018-2029)
7.2 Europe Influenza Diagnostics Market Size by Type
7.2.1 Europe Influenza Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Influenza Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Influenza Diagnostics Market Share by Type (2018-2029)
7.3 Europe Influenza Diagnostics Market Size by Application
7.3.1 Europe Influenza Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Influenza Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Influenza Diagnostics Market Share by Application (2018-2029)
7.4 Europe Influenza Diagnostics Market Size by Country
7.4.1 Europe Influenza Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Influenza Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Influenza Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Influenza Diagnostics Market Size (2018-2029)
8.2 China Influenza Diagnostics Market Size by Type
8.2.1 China Influenza Diagnostics Market Size by Type (2018-2023)
8.2.2 China Influenza Diagnostics Market Size by Type (2024-2029)
8.2.3 China Influenza Diagnostics Market Share by Type (2018-2029)
8.3 China Influenza Diagnostics Market Size by Application
8.3.1 China Influenza Diagnostics Market Size by Application (2018-2023)
8.3.2 China Influenza Diagnostics Market Size by Application (2024-2029)
8.3.3 China Influenza Diagnostics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Influenza Diagnostics Market Size (2018-2029)
9.2 Asia Influenza Diagnostics Market Size by Type
9.2.1 Asia Influenza Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Influenza Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Influenza Diagnostics Market Share by Type (2018-2029)
9.3 Asia Influenza Diagnostics Market Size by Application
9.3.1 Asia Influenza Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Influenza Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Influenza Diagnostics Market Share by Application (2018-2029)
9.4 Asia Influenza Diagnostics Market Size by Region
9.4.1 Asia Influenza Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Influenza Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Influenza Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Influenza Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Influenza Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Influenza Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2018-2023)
11.1.5 BD Recent Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2018-2023)
11.2.5 Abbott (Include Alere) Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2018-2023)
11.3.5 Roche Recent Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2018-2023)
11.4.5 SIEMENS Recent Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2018-2023)
11.5.5 Analytik Jena Recent Developments
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2018-2023)
11.6.5 Quidel Recent Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2018-2023)
11.7.5 Thermo Fisher Recent Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2018-2023)
11.8.5 Meridian Bioscience Recent Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2018-2023)
11.9.5 BioMerieux Recent Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2018-2023)
11.10.5 Sekisui Diagnostics Recent Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2018-2023)
11.11.5 Response Biomedical Recent Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2018-2023)
11.12.5 SA Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of RIDT
Table 3. Key Players of RT-PCR
Table 4. Key Players of Cell Culture
Table 5. Key Players of Others
Table 6. Global Influenza Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Influenza Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Influenza Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Influenza Diagnostics Market Share by Region (2018-2023)
Table 10. Global Influenza Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Influenza Diagnostics Market Share by Region (2024-2029)
Table 12. Influenza Diagnostics Market Trends
Table 13. Influenza Diagnostics Market Drivers
Table 14. Influenza Diagnostics Market Challenges
Table 15. Influenza Diagnostics Market Restraints
Table 16. Global Influenza Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Influenza Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2022)
Table 19. Global Influenza Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Influenza Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Influenza Diagnostics, Product and Application
Table 23. Global Key Players of Influenza Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Influenza Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Influenza Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Influenza Diagnostics Revenue Share by Application (2024-2029)
Table 33. North America Influenza Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Influenza Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Influenza Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Influenza Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Influenza Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Influenza Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Influenza Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Influenza Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Influenza Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Influenza Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Influenza Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Influenza Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Influenza Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Influenza Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Influenza Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Influenza Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Influenza Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Influenza Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Influenza Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Influenza Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Influenza Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Influenza Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Influenza Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Influenza Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Influenza Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Influenza Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Influenza Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 65. BD Company Details
Table 66. BD Business Overview
Table 67. BD Influenza Diagnostics Product
Table 68. BD Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 69. BD Recent Developments
Table 70. Abbott (Include Alere) Company Details
Table 71. Abbott (Include Alere) Business Overview
Table 72. Abbott (Include Alere) Influenza Diagnostics Product
Table 73. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Abbott (Include Alere) Recent Developments
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Influenza Diagnostics Product
Table 78. Roche Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Roche Recent Developments
Table 80. SIEMENS Company Details
Table 81. SIEMENS Business Overview
Table 82. SIEMENS Influenza Diagnostics Product
Table 83. SIEMENS Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 84. SIEMENS Recent Developments
Table 85. Analytik Jena Company Details
Table 86. Analytik Jena Business Overview
Table 87. Analytik Jena Influenza Diagnostics Product
Table 88. Analytik Jena Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Analytik Jena Recent Developments
Table 90. Quidel Company Details
Table 91. Quidel Business Overview
Table 92. Quidel Influenza Diagnostics Product
Table 93. Quidel Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Quidel Recent Developments
Table 95. Thermo Fisher Company Details
Table 96. Thermo Fisher Business Overview
Table 97. Thermo Fisher Influenza Diagnostics Product
Table 98. Thermo Fisher Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Thermo Fisher Recent Developments
Table 100. Meridian Bioscience Company Details
Table 101. Meridian Bioscience Business Overview
Table 102. Meridian Bioscience Influenza Diagnostics Product
Table 103. Meridian Bioscience Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 104. Meridian Bioscience Recent Developments
Table 105. BioMerieux Company Details
Table 106. BioMerieux Business Overview
Table 107. BioMerieux Influenza Diagnostics Product
Table 108. BioMerieux Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 109. BioMerieux Recent Developments
Table 110. Sekisui Diagnostics Company Details
Table 111. Sekisui Diagnostics Business Overview
Table 112. Sekisui Diagnostics Influenza Diagnostics Product
Table 113. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 114. Sekisui Diagnostics Recent Developments
Table 115. Response Biomedical Company Details
Table 116. Response Biomedical Business Overview
Table 117. Response Biomedical Influenza Diagnostics Product
Table 118. Response Biomedical Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Response Biomedical Recent Developments
Table 120. SA Scientific Company Details
Table 121. SA Scientific Business Overview
Table 122. SA Scientific Influenza Diagnostics Product
Table 123. SA Scientific Revenue in Influenza Diagnostics Business (2018-2023) & (US$ Million)
Table 124. SA Scientific Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Influenza Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. RIDT Features
Figure 4. RT-PCR Features
Figure 5. Cell Culture Features
Figure 6. Others Features
Figure 7. Global Influenza Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Influenza Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. POCT Case Studies
Figure 11. Others Case Studies
Figure 12. Influenza Diagnostics Report Years Considered
Figure 13. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Influenza Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Influenza Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Influenza Diagnostics Market Share by Players in 2022
Figure 17. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2022
Figure 19. North America Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Influenza Diagnostics Market Share by Type (2018-2029)
Figure 21. North America Influenza Diagnostics Market Share by Application (2018-2029)
Figure 22. North America Influenza Diagnostics Market Share by Country (2018-2029)
Figure 23. United States Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Influenza Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Influenza Diagnostics Market Share by Type (2018-2029)
Figure 27. Europe Influenza Diagnostics Market Share by Application (2018-2029)
Figure 28. Europe Influenza Diagnostics Market Share by Country (2018-2029)
Figure 29. Germany Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Influenza Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Influenza Diagnostics Market Share by Type (2018-2029)
Figure 37. China Influenza Diagnostics Market Share by Application (2018-2029)
Figure 38. Asia Influenza Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Influenza Diagnostics Market Share by Type (2018-2029)
Figure 40. Asia Influenza Diagnostics Market Share by Application (2018-2029)
Figure 41. Asia Influenza Diagnostics Market Share by Region (2018-2029)
Figure 42. Japan Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Influenza Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Influenza Diagnostics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Influenza Diagnostics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Influenza Diagnostics Market Share by Country (2018-2029)
Figure 52. Brazil Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Influenza Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. BD Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 59. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 60. Roche Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 61. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 62. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 63. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 64. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 65. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 66. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 67. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 68. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 69. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs